In what is becoming an annual tradition here on “The Weekly Bioanalysis” podcast, Dom and John take a bit of time to take a look back at 2022’s Fierce 15 (the annual selected list of impressively performing companies across the biotech world, highlighting a broad range of teams, leaders and science, as selected by the Fierce Biotech group). In addition to this, the guys discuss the list of drugs that received approvals throughout 2022, then they discuss the trends they see emerging from these industry lists… and what it means as we begin 2023.


To view/listen to the episode of “the Weekly Bioanalysis” click the play button below!


You can always find the latest episode of “The Weekly Bioanalysis” here,

but you can also subscribe to the podcast on Apple Podcasts or any of the major podcast distribution channels!


We would love to hear from you about questions you have from our podcast – or even feedback on how we could improve it!

Please use the form below to reach out to us.

Scroll to Top